Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
Clinical trials sponsored by Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla, explained in plain language.
-
New hope for stroke patients: which blood thinner works best after emergency artery repair?
Disease control CompletedThis study tested two blood thinners—tirofiban and aspirin—in 240 people who had a stroke caused by blockages in both the neck and brain arteries. After emergency surgery to open the arteries, patients received one of the two drugs to prevent the neck artery from reclogging. The …
Phase: PHASE4 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 26, 2026 05:08 UTC
-
Mediterranean diet shows promise in battling fatty liver
Disease control CompletedThis study looked at whether a Mediterranean diet, sometimes combined with exercise, could help people with a type of fatty liver disease called MASLD. The goal was to see if the diet could reduce fat and scarring in the liver. 96 adults with confirmed MASLD took part. The result…
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New antibiotic shows promise against superbug blood infections
Disease control CompletedThis study tested whether an older antibiotic, temocillin, works as well as a stronger one, meropenem, for treating blood infections caused by drug-resistant bacteria. Over 300 adults took part, receiving either antibiotic for 7 to 14 days. The goal was to see if temocillin could…
Phase: PHASE3 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 14, 2026 12:04 UTC